Company Data
Acumen Pharmaceuticals Inc.
Ticker
ABOS
Current Price
$2.12 -0.93%
Market Cap
$128.4M
Price Target
Refer to Report
Volume
437.4K
52wk Range
$0.8551 - $3.36
Overview
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease. The company’s lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.